$120.85$150.99
Prepare to embark on a sensory journey with the Bosco Apple, a fruit that transcends the ordinary and promises an unparalleled taste experience. These apples are nothing short of nature’s masterpiece, celebrated for their distinctive blend of flavors and their captivating visual allure.
Availability: In Stock
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
₹142
INTRODUCTION AIM7 30XR TABLET is a combination of Gliclazide, Metformin and Pioglitazone which belongs to the group of medicines called Antidiabetic agents. It is used in adults to manage type II diabetes mellitus when diet, exercise and treatment with single age...
AIM7 30XR TABLET is a combination of Gliclazide, Metformin and Pioglitazone which belongs to the group of medicines called Antidiabetic agents. It is used in adults to manage type II diabetes mellitus when diet, exercise and treatment with single agents does not result in adequate sugar control.
Type II diabetes mellitus is a chronic disease characterized by abnormally high levels of glucose in the blood. It is caused due to inadequate production of a hormone called insulin (produced by pancreas to metabolize glucose) in the body or due to inadequate sensitivity of body cells to the actions of insulin.
Before taking AIM7 30XR TABLET, inform your doctor if you have any liver, kidney or heart problems. You must also inform your doctor if you have any eye problems, hormonal imbalance, alcoholism, or if you are malnourished, starved, on an irregular diet as a precaution.
AIM7 30XR TABLET is strictly not recommended for use in patients with type I diabetes mellitus, bladder cancer, severe heart failure or lactic acidosis. It is also not suitable for use in pregnant or breastfeeding women.
Along with the treatment, follow the diet and lifestyle changes advised by your doctor to achieve better results. Avoid smoking and consumption of alcohol while taking AIM7 30XR TABLET as it may aggravate your existing condition.
The most common side effects of taking AIM7 30XR TABLET are low blood sugar levels, nausea, stomach upset, constipation, sore throat, muscle pain, headache, dizziness and weight gain. Consult your doctor if any of these side effect worsens.
AIM7 30XR TABLET stimulates the pancreas to secrete more insulin (a hormone involved in glucose metabolism). It also makes our body more sensitive to insulin which helps in digesting the circulating sugars (glucose) in the blood, thereby reducing blood sugar levels. Additionally, it can also reduce the glucose produced by the liver and reduces its absoprtion in the body.
Take AIM7 30XR TABLET preferably just before meals or during meals or as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine.
Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and disease condition.
Do not stop taking AIM7 30XR TABLET unless your doctor advice you to stop.
Stop taking AIM7 30XR TABLET and contact your doctor immediately if you experience any of the following side effects:
To manage flatulence, consider dietary adjustments and lifestyle changes. Identify and limit gas-producing foods such as beans, cabbage, and carbonated drinks. Chew food thoroughly to aid digestion and reduce the likelihood of swallowing air. Introduce probiotics through yogurt or supplements to promote a healthy gut flora. Regular physical activity can also aid digestion. If persistent, consult a healthcare professional to rule out underlying issues and discuss potential solutions, such as medications or further dietary modifications.
Managing dizziness involves addressing potential underlying causes and making lifestyle adjustments. If you experience sudden or severe dizziness, it's important to sit or lie down to prevent the risk of falling. Ensure proper hydration and maintain a balanced diet to regulate blood sugar levels. Avoid sudden movements and try to rise slowly from a seated or lying position. If dizziness persists, it's advisable to consult with a healthcare professional to rule out any serious medical conditions.
Stay well-hydrated, as dehydration can contribute to headaches. Get adequate rest and maintain a regular sleep schedule. Practice stress-management techniques, such as deep breathing or meditation, to alleviate tension. Over-the-counter pain relievers like acetaminophen or ibuprofen can provide relief, but it's essential to follow recommended dosages. Applying a cold or warm compress to the forehead may also ease discomfort. If headaches persist or worsen, seek medical advice to rule out underlying issues and receive appropriate treatment.
Managing hypoglycemia, or low blood sugar, involves prompt action to raise blood glucose levels and prevent complications. When experiencing hypoglycemia, individuals should quickly consume a source of rapidly-absorbed carbohydrates, such as glucose tablets, fruit juice, or regular soda. Waiting for about 15 minutes and rechecking blood sugar levels is crucial to ensure they rise to a safe range. If hypoglycemia persists, additional carbohydrate intake may be necessary. Once blood sugar levels stabilize, a small snack containing both carbohydrates and protein can help sustain them. Regular monitoring and consultation with a healthcare professional are essential for developing a personalized plan to manage hypoglycemia effectively. In severe cases, emergency assistance may be required.
To manage nausea and vomiting, it is essential to focus on hydration, rest, and dietary adjustments. Stay well-hydrated by sipping on clear fluids like water or ginger tea. Opt for small, frequent meals to ease the digestive process, avoiding strong-smelling or heavy foods. Ginger, known for its anti-nausea properties, can be consumed through tea or candies. Adequate rest is crucial for recovery, allowing your body to heal. If symptoms persist, consult a healthcare professional who may recommend medications or other interventions tailored to the underlying cause of nausea and vomiting.
AIM7 30XR TABLET is not recommended for use in pregnant women. Therefore, consult your doctor before taking it.
AIM7 30XR TABLET is not recommended for use in breastfeeding women. Therefore, consult your doctor before taking it.
Do not drive or operate any heavy tools or machines if your ability is affected by AIM7 30XR TABLET.
Avoid consumption of alcohol while taking AIM7 30XR TABLET as it may increase the risk of unwanted side effects.
AIM7 30XR TABLET is not recommended for use in patients with severe kidney problems. It should be used with caution in patients with other kidney problems. Therefore, consult your doctor before taking it.
AIM7 30XR TABLET is not recommended for use in patients with severe liver problems. It should be used with caution in patients with other liver problems. Therefore, consult your doctor before taking it.
Do not take AIM7 30XR TABLET if you are allergic to Gliclazide, Metformin, Pioglitazone or to any other sulfonylureas (Ex. glyburide, glimepiride) or sulphonamides (Ex. sulfasalazine).
AIM7 30XR TABLET is not recommended for use in patients with breathing problems (such as asthma or COPD). Therefore, consult your doctor before taking it.
AIM7 30XR TABLET is not recommended for use in patients with severe heart problems (such as heart failure). It should be used with caution in patients with other heart problems. Therefore, consult your doctor before taking it.
AIM7 30XR TABLET is not recommended for use in children and in adolescents (aged below 18 years). Therefore, consult your doctor before taking it.
AIM7 30XR TABLET should be used with caution in elderly patients (aged above 65 years). Therefore, consult your doctor before taking it.
AIM7 30XR TABLET is not recommended for use if you:
Before taking AIM7 30XR TABLET, inform your doctor if you:
A. Drug-Drug Interactions:
Before taking AIM7 30XR TABLET, inform your doctor if you are taking any of the following medicines:
Overdosage:
If you or anyone else accidentally took more AIM7 30XR TABLET, you may experience the signs of hypoglycemia (such as increased hunger, sweating, headache, feeling clammy, restless or aggressive, shakiness, fast heartbeat and confusion). To manage this, consume any sugary food immediately. If the symptom did not improve or worsens contact your doctor immediately. Other symptoms of overdosage might include vomiting, stomach pain with muscle cramps, feeling generally unwell with severe tiredness and difficulty in breathing.
| Drug | : |
Gliclazide, Metformin, Pioglitazone |
| Pharmacological Category | : |
Sulfonylureas, Biguanides, PPAR-gamma and PPAR-alpha agonists |
| Therapeutic Indication | : | Type II diabetes mellitus |
| Dosage Forms | : | Tablet |
A: AIM7 30XR TABLET is an antidiabetic medicine used in the management of Type II diabetes mellitus when diet, exercise and treatment with single agents does not result in adequate response.
A: Take AIM7 30XR TABLET preferably just before meals or during meals or as advised by your physician. Swallow the medicine with a glass of water. Do not cursh or chew the medicine. Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and disease condition.
A: You need to take AIM7 30XR TABLET as long as your doctor or physician prescribes you the medicine. Your doctor will decide the correct dose and duration of therapy for you depending upon your age, body weight and disease condition.
A: AIM7 30XR TABLET must be just before meals or during meals to avoid gastrointestinal side effects.
A: If you forgot to take a dose of AIM7 30XR TABLET, take it as soon as you remember. However, if it is time for the next dose of AIM7 30XR TABLET, skip the missed dose and take the next one regularly. Do not take a double dose of AIM7 30XR TABLET to compensate the missed ones.
A: No. You should not stop taking AIM7 30XR TABLET without consulting your doctor because it may lead to reversal of symptoms. If you feel better after using AIM7 30XR TABLET, consult your doctor for advice.
A: No, taking a higher dose of AIM7 30XR TABLET will not be effective rather it can lead to toxicity. Always take the dose prescribed by your doctor. If the prescribed dose is not effective for you, consult your doctor for advice. Your doctor might increase the dose or suggest an alternative therapy.
A: It is not advisable to take medicines to control blood pressure while taking AIM7 30XR TABLET without consulting your doctor, as they have known interactions with AIM7 30XR TABLET.
A: Low blood sugar is a common side effect of taking AIM7 30XR TABLET. Try to have sugar rich food items such as fruit juice, glucose tablets or gel, soft drinks, honey or sugary candy. Check your blood sugar after 10 minutes. If not gained optimum level, take another sugary snack, or drink, and check the blood sugar levels once again. If your condition did not improve, consult your doctor immediately.
A: Co-administration of AIM7 30XR TABLET with insulin is considered risky as they can increase the chances of hypoglycemia (low blood sugar levels). Therefore, consult your doctor before taking it.
A: AIM7 30XR TABLET is not recommended for use in pregnant women. Therefore, consult your doctor for advice before taking it.
A: AIM7 30XR TABLET may cause bone fractures in some individuals. Therefore, it is important for you to inform your doctor before taking AIM7 30XR TABLET if you have any bone problems or at risk of developing any bone fractures (such as menopause).
A: Yes. AIM7 30XR TABLET may cause weight gain in some individuals. To avoid this, follow a healthy diet and regular physical activity as advised by your physician. However, if you experience any weight gain due to swelling of body parts (such as in face, legs, or hands), consult your doctor immediately.
A: The most common side effects of taking AIM7 30XR TABLET are low blood sugar levels, nausea, stomach upset, constipation, sore throat, muscle pain, headache, dizziness and weight gain. Consult your doctor if any of these side effect worsens.
1. KD. Tripathi. Insulin, Oral Hypoglycaemic Drugs and Glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page – 270, 275 & 276.
2. Glyn Belcher, Ceri Lambert, Gareth Edwards, Richard Urquhart, David R Matthews. Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes. NIH. National Library of Medicine. National Center for Biotechnology Information. PMC. PubMed Central. October 2005. [Accessed on 27th January 2024] https://pubmed.ncbi.nlm.nih.gov/16002175/
3. Milpharm Limited. Electronic Medicines Compendium (EMC). [Revised in June 2020] [Accessed on 27th January 2024] https://www.medicines.org.uk/emc/files/pil.594.pdf
4. Rx Farma Limited. Electronic Medicines Compendium (EMC). [Revised in September 2019] [Accessed on 27th January 2024] https://www.medicines.org.uk/emc/files/pil.11951.pdf
5. Gerard Laboratories. Electronic Medicines Compendium (EMC). [Revised in August 2020] [Accessed on 27th January 2024] https://www.medicines.org.uk/emc/files/pil.8836.pdf
6. Les Laboratories Servier Industrie. Gliclazide. Diamicron 30mg MR Tablet. Electronic Medicines Compendium (EMC). [Revised in July 2022] [Accessed on 27th January 2024] https://www.medicines.org.uk/emc/files/pil.1321.pdf
7. Milpharm Limited. Gliclazide 80mg Tablets. Electronic Medicines Compendium (EMC). [Revised in March 2022] [Accessed on 27th January 2024] https://www.medicines.org.uk/emc/files/pil.7023.pdf
8. Brown & Burk UK Ltd. Gliclazide 40 mg Tablets. Electronic Medicines Compendium (EMC). [Revised in December 2020] [Accessed on 27th January 2024] https://www.medicines.org.uk/emc/files/pil.13135.pdf
9. Panacea Biotec Limited. Glizid Total P 15. Gliclazide SR 60mg + Metformin SR 500mg + Pioglitazone 15mg. [Revised in July 2019]. [Accessed on 27th January 2024] https://media.panaceabiotec.com/documents/2019/7/27/ProductMonograph-GlizidTotalP15.pdf
10. Central Drugs Standard Control Organization. Metformin SR 500mg/500mg + GliclazideSR 60mg/30mg + Pioglitazone 15mg/15mg tablets. May 2010. [Accessed on 27th January 2024] https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/UploadApprovalNewDrugs/dciApprovedfdc.pdf
Written By Srilekha. R, B.Pharm
Last updated on 31 Jan 2024 | 04:24 PM(IST)